BioSpace News Archive

The U.S. Food and Drug Administration took steps to help prevent disruptions in the food supply-chain by issuing a temporary policy for FDA Food Safety Modernization Act supplier verification onsite audit requirements during the coronavirus public health emergency.

NKMax America announced that Dr. Paul Song, Vice Chairman and Chief Medical Officer of NKMax America, has been selected to present at the upcoming NIH-AACR Cancer, Autoimmunity, and Immunology Conference on March 23-24, 2020.

Hagens Berman urges RTI Surgical Holdings, Inc. investors who have suffered significant losses to submit their loss now.

Manufacturers of soy protein are betting stakes on eco-friendliness and sustainability to attract consumers. They are seeking profitability prospects in the growing preference towards plant-based food products. Trends like veganism are strengthening the growth trajectory of the soy protein market.

Enzychem Lifesciences (KOSDAQ: 183490) today announced that it is advancing a domestic clinical trial of EC-18, a new coronavirus treatment candidate, in South Korea

Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), today announced that last week it began communication with domestic and international agencies and groups to be a supplier of mesenchymal stem cells (MSCs) for the potential clinical treatment of patients suffering from secondary issues related to the coronavirus (COVID-19)

Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $45 million in a Series B financing.

Todos Medical Ltd. (OTCQB: TOMDF), a pre-commercial stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today announced that it has entered into a non-exclusive distribution agreement with 3DMedicine Science & Technology Co (3DMed)

Pristine Surgical LLC, makers of the first fully-integrated, single-use visualization platform for rigid endoscopic surgical and diagnostic procedures, announced today that it completed its third round of investment capital raising

Sartorius will postpone its Annual General Shareholders’ Meeting formerly scheduled for March 26, 2020, to a later date due to the coronavirus pandemic and the associated restrictive rules imposed on meetings.